MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CORT has $814,881K in assets. $176,894K in debts. $108,738K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
285.57%
Quick Ratio
276.93%
Cash Ratio
72.89%
Debt to Asset Ratio
21.71%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Deferred tax assets, net
    • Long-term marketable securities
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Treasury stock
    • Retained earnings
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
108,738 120,495 125,138 102,745
Short-term marketable securities
229,446 251,657 296,545 239,481
Trade receivables, net of allowances
39,072 59,786 69,629 64,567
Inventory
12,890 12,868 12,349 12,276
Prepaid expenses and other current assets
35,887 40,658 37,469 24,043
Total current assets
426,033 485,464 541,130 443,112
Strategic inventory
14,506 11,094 12,002 7,991
Operating lease right-of-use asset
7,196 4,583 4,776 4,964
Property and equipment, net
3,171 1,890 2,094 2,348
Long-term marketable securities
177,261 160,270 102,557 172,775
Other assets
5,153 5,153 8,049 8,303
Deferred tax assets, net
181,561 168,197 152,999 162,229
Total assets
814,881 836,651 823,607 801,722
Accounts payable
33,306 40,444 34,446 23,525
Accrued research and development expenses
34,091 33,954 28,322 29,049
Accrued and other liabilities
80,161 90,603 108,447 91,073
Short-term operating lease liability
1,627 1,084 1,050 1,017
Total current liabilities
149,185 166,085 172,265 144,664
Long-term operating lease liability
8,010 5,023 5,308 5,588
Long-term accrued government rebates
4,367 2,562 --
Long-term accrued income taxes payable
15,332 15,176 14,132 15,677
Total liabilities
176,894 188,846 191,705 165,929
Preferred stock
0 -0 0
Common stock, par value 0.001 per share, 280,000 shares authorized and 142,518 issued and 105,966 outstanding as of december31, 2025 and 137,753 shares issued and 105,113 outstanding as of december31, 2024
-140 139 138
Common stock
141 ---
Treasury stock
976,688 966,586 923,290 866,931
Additional paid-in capital
1,001,990 968,600 933,613 900,864
Accumulated other comprehensive income
918 2,264 2,341 2,291
Retained earnings
611,626 643,387 619,099 599,431
Total stockholders equity
637,987 647,805 631,902 635,793
Total liabilities and stockholders equity
814,881 836,651 823,607 801,722
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$229,446K Cash and cashequivalents$108,738K Trade receivables,net of allowances$39,072K Prepaid expenses andother current assets$35,887K Inventory$12,890K Total current assets$426,033K Deferred tax assets, net$181,561K Long-term marketablesecurities$177,261K Strategic inventory$14,506K Operating leaseright-of-use asset$7,196K Other assets$5,153K Property and equipment,net$3,171K Total assets$814,881K Total liabilities andstockholders equity$814,881K Total stockholdersequity$637,987K Total liabilities$176,894K Treasury stock$976,688K Additional paid-in capital$1,001,990K Total currentliabilities$149,185K Long-term accrued incometaxes payable$15,332K Long-term operating leaseliability$8,010K Long-term accruedgovernment rebates$4,367K Retained earnings$611,626K Accumulated othercomprehensive income$918K Common stock$141K Accrued and otherliabilities$80,161K Accrued research anddevelopment expenses$34,091K Accounts payable$33,306K Short-term operating leaseliability$1,627K

CORCEPT THERAPEUTICS INC (CORT)

CORCEPT THERAPEUTICS INC (CORT)